This announcement is a separate document:
天茂集团：天茂集团2024年第二次临时股东大会法律意见书
Hubei Biocause Pharmaceutical: Legal opinion for the second extraordinary shareholders meeting of Hubei Biocause Pharmaceutical in 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.